AVELUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Wed Apr 02 09:50:45 GMT 2025` Edited by `admin` on `Wed Apr 02 09:50:45 GMT 2025`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	KXG2PJ551I
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

AVELUMAB

Official Name

English

BAVENCIO

Preferred Name

English

AVELUMAB [USAN]

Common Name

English

MSB0010682

Code

English

AVELUMAB [MI]

Common Name

English

avelumab [INN]

Common Name

English

MSB0010718C

Common Name

English

Avelumab [WHO-DD]

Common Name

English

MSB-0010682

Code

English

IMMUNOGLOBULIN G1-LAMBDA1, ANTI-(HOMO SAPIENS CD274 (PROGRAMMED DEATH LIGAND 1, PDL1, PD-L1, B7 HOMOLOG 1, B7H1)), HOMO SAPIENS MONOCLONAL ANTIBODY

Common Name

English

AVELUMAB [JAN]

Common Name

English

AVELUMAB [PURPLE BOOK CDER]

Common Name

English

MSB-0010718C

Common Name

English

Classification Tree Code System Code

WHO-ATC

L01XC31

Created by admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025

NCI_THESAURUS

C128057

Created by admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025

FDA ORPHAN DRUG

491815

Created by admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025

NDF-RT

N0000193338

Created by admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025

FDA ORPHAN DRUG

604117

Created by admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025

EU-Orphan Drug

EU/3/15/1590

Created by admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025

Code System Code Type Description

DAILYMED

KXG2PJ551I

Created by admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025

PRIMARY

DRUG CENTRAL

5221

Created by admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025

PRIMARY

SMS_ID

100000166075

Created by admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025

PRIMARY

EVMPD

SUB180078

Created by admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025

PRIMARY

USAN

DE-160

Created by admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025

PRIMARY

RXCUI

1875534

Created by admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025

PRIMARY

CAS

1537032-82-8

Created by admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025

PRIMARY

DRUG BANK

DB11945

Created by admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025

PRIMARY

NCI_THESAURUS

C116870

Created by admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025

PRIMARY

FDA UNII

KXG2PJ551I

Created by admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025

PRIMARY

WIKIPEDIA

Avelumab

Created by admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025

PRIMARY

MERCK INDEX

m11986

Created by admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025

PRIMARY

INN

10062

Created by admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025

PRIMARY

LACTMED

Avelumab

Created by admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025

PRIMARY

From	To
1_22	1_96
1_147	1_203
1_264	1_324
1_370	1_428
2_22	2_96
2_147	2_203
2_264	2_324
2_370	2_428
3_22	3_90
3_138	3_197
4_22	4_90
4_138	4_197
1_223	3_215
2_223	4_215
1_229	2_229
1_232	2_232

Glycosylation Type

MAMMALIAN

Glycosylation Link Type	Site
N	1_300
N	2_300

Related Record Type Details


					L4766ELH5T

PROGRAMMED CELL DEATH 1 LIGAND 1

TARGET -> INHIBITOR

Related Record Type Details


					KXG2PJ551I

AVELUMAB

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Biological Half-life	PHARMACOKINETIC

Volume of Distribution	PHARMACOKINETIC

MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL